Revolutionizing the Diagnosis of Acute Infection and Sepsis With Cutting-Edge Host Response Diagnostics With the TriVerity Test System

[INF-04 Study] ​This symposium will present unmet needs in assessing patients for acute infection and sepsis, the promise of host response as a better approach to address these needs, breaking results from the Sepsis-Shield study, and how the TriVerity(tm) Acute Infection and Sepsis test (Inflammatix, Inc.) may be used in routine care once cleared. The TriVerity Test is in development, is not for sale, and does not have marketing approval or clearance from regulatory authorities in any jurisdiction.